Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for an HIV-vaccine.

H Wigzell1

  • 1Department of Immunology, Karolinska Institute, Stockholm, Sweden.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|July 1, 1991
PubMed
Summary

Developing an effective human immunodeficiency virus (HIV) vaccine is a critical need. Favorable virus characteristics suggest that an HIV vaccine is feasible, supported by animal and human studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Professor emeritus Jacob B. Natvig, one of the founders of Scandinavian journal of immunology, turns 75.

Scandinavian journal of immunology·2009
Same author

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

International journal of immunogenetics·2008
Same author

T cell receptor V gene usage by CD4+ and CD8+ peripheral blood T lymphocytes in immune thrombocytopenic purpura.

Acta paediatrica (Oslo, Norway : 1992)·2004
Same author

Hsp90 binds CpG oligonucleotides directly: implications for hsp90 as a missing link in CpG signaling and recognition.

Cellular and molecular life sciences : CMLS·2003
Same author

Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae.

Clinical and experimental immunology·2002
Same author

Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation.

Thorax·2002

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Human immunodeficiency virus (HIV) infection remains a significant global health challenge requiring effective prevention strategies.
  • The development of an HIV vaccine is a high priority due to the limitations of current treatments.

Purpose of the Study:

  • To evaluate the feasibility of developing an HIV vaccine.
  • To review existing animal and human studies on HIV/SIV vaccines.

Main Methods:

  • Review of scientific literature on HIV/SIV vaccine research.
  • Analysis of HIV's biological characteristics relevant to vaccine development.

Main Results:

  • HIV exhibits a low rate of infection transmission per contact.
  • The typical incubation period for HIV disease in adults is 5-10 years.
  • Existing vaccine studies in animals and humans provide support for the potential development of an effective HIV vaccine.

Conclusions:

  • The inherent biological properties of HIV are favorable for vaccine development.
  • Current research and historical studies indicate a promising outlook for creating a successful HIV vaccine to achieve sterilizing or protective immunity.

Related Experiment Videos